Skip to main content

Site notifications

(Approval lapsed) Sertraline 50mg tablets, USP (Cipla)

Section 19A approved medicine
(Approval lapsed) Sertraline 50mg tablets, USP (Cipla)
Section 19A approval holder
Medsurge Healthcare Pty Ltd ABN 92 124 728 892
Phone
1300 788 261
Approved until
Status
Expired
Medicines in short supply/unavailable
APO-SERTRALINE sertraline (as hydrochloride) 50 mg tablet blister pack - ARTG 213177
Indication(s)

Indicated for the treatment of children (aged 6 years of age and older) and adolescents with obsessive compulsive disorder (OCD).

Indicated in adults for the treatment of:

  • Major depression
  • Obsessive compulsive disorder (OCD)
  • Panic disorder
  • Social phobia (social anxiety disorder) and the prevention of its relapse
  • Pre-menstrual dysphoric disorder (PMDD) as defined by DSM-IV criteria
Published

Help us improve the Therapeutic Goods Administration site